Why is P & G Health Ltd falling/rising?

As of 14-Aug, Procter & Gamble Health Ltd's stock price is rising, currently at 6,286.30, reflecting an increase of 89.3 points or 1.44%. The stock has shown strong performance recently, with a 1-month return of 8.35% and a year-to-date return of 20.20%. It is also close to its 52-week high, just 3.24% away from Rs 6490. Today's trading performance indicates that the stock outperformed its sector by 1.32%, and there has been a notable increase in investor participation, with delivery volume rising by 9.54% against the 5-day average. The company has demonstrated high management efficiency, a low debt-to-equity ratio, and positive results over the last four quarters, contributing to its favorable market position.
In the broader market context, while the BSE500 index has generated negative returns of -0.57% over the past year, Procter & Gamble Health Ltd has significantly outperformed with a return of 23.57%. This contrast highlights the stock's resilience and appeal to investors, particularly given its high institutional holdings of 21.15%, which suggests confidence from more knowledgeable investors. However, it is important to note that despite these positive indicators, the company faces risks related to its long-term growth potential, as net sales and operating profit growth rates have been relatively modest over the past five years.